Pajares, Marķa J <br/><br/>
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2012 
 - 1129-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2011.37.4231  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Adenocarcinoma of Lung<br/>Aged<br/>Analysis of Variance<br/>Angiogenesis Inhibitors--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Squamous Cell--blood supply<br/>Cohort Studies<br/>Disease Progression<br/>Europe<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Lung Neoplasms--blood supply<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Odds Ratio<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Vascular Endothelial Growth Factor--drug effects<br/>Risk Factors<br/>Signal Transduction--drug effects<br/>Treatment Outcome<br/>Up-Regulation<br/>Vascular Endothelial Growth Factor A--drug effects<br/>Vascular Endothelial Growth Factor Receptor-1--metabolism<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism